Research Study on Whether a Combination of 2 Medicines Works in People With Non-alcoholic Steatohepatitis (NASH)

Study of 2 medicine combinations for adults with NASH

Age
18 years - 99 years
Gender
All
participants needed
75
Location
1
Find a site
Research Study on Whether a Combination of 2 Medicines Works in People With Non-alcoholic Steatohepatitis (NASH)

Brief description of study

This study is being done to see if a combination of 2 medicines (called NNC0194-0499 and semaglutide) can reduce liver damage in patients with non alcoholic steatohepatitis (NASH). NNC0194-0499 is a new medicine which works in the liver. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabetes in many countries. It also helps with weight loss and may reduce liver damage, and so prevent future liver complications. It works in a different way to NNC0194 0499. The 2 medicines may work better together than on their own. The study will also look at a combination of semaglutide and another weight-loss medicine called NNC0174-0833, which may be another treatment option for NASH.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Non-alcoholic Steatohepatitis,NASH
  • Age: 18 years - 99 years
  • Gender: All

Male or Female Age 18 or older Histological evidence of NASH

The purpose of this research study is to learn whether combinations of 2 medicines can reduce liver damage in adults with non-alcoholic steatohepatitis (NASH).

Participants will receive a combination of 2 medicines. One combination includes a medicine that works in the liver together with a medicine that is used to treat type 2 diabetes and is also used for weight loss. The study will also look at a second combination that includes that same diabetes and weight-loss medicine together with another weight-loss medicine.

Who can participate:
Adults with NASH may be able to participate if they:

  • Are age 18 or older
  • Have NASH confirmed by a liver tissue test (biopsy)

Updated on 04 Aug 2024. Study ID: 849168

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Please provide your preferred way of contact
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center